Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Mark H. Lynch is Co-Chair of the firm's Pharmaceutical Litigation and Government Investigations Group.  He has tried cases and argued appeals involving a wide variety of civil and criminal matters in state and federal courts throughout the country, including the US Supreme Court.  In recent years, his practice has focused on representation of pharmaceutical manufacturers in complex, multi-district civil litigation involving parallel state and federal proceedings which are often triggered by government investigations.  Mr. Lynch has defended major pharmaceutical companies in class actions challenging pricing practices and in nationwide product liability litigation. He has experience in various types of fraud and breach of fiduciary duty cases, RICO, grand jury investigations, internal corporate investigations, and product liability litigation.

  • Best Lawyers in America, Bet-the-Company Litigation and Commercial Litigation (2014-2018)
  • Washington DC Super Lawyers, Class Action (2014-2017)
  • LMG Life Sciences, "Life Science Star" (2013)